Atrioventricular nodal ablation versus antiarrhythmic drugs after permanent pacemaker implantation for bradycardia-tachycardia syndrome View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-04-20

AUTHORS

Yasutsugu Nagamoto, Tomohito Inage, Teruhisa Yoshida, Tomohiro Takeuchi, Takeki Gondo, Yujiro Fukuda, Eiichi Takii, Kenta Murotani, Tsutomu Imaizumi

ABSTRACT

Patients often require antiarrhythmic drugs to control tachycardia after permanent pacemaker implantation (PMI) for bradycardia-tachycardia syndrome. We compared atrioventricular nodal ablation (AVNA) to antiarrhythmic drugs after PMI for bradycardia-tachycardia syndrome. Twenty-eight symptomatic patients with bradycardia-tachycardia syndrome, all of which had a long pause after termination of paroxysmal atrial fibrillation, underwent PMI with RV lead placement at the mid-septum site. Among these patients, 14 underwent PMI and AVNA (AVNA group). The remaining 14 patients underwent PMI only, and continued to take anti-arrhythmic drugs (drug group). We compared cardiac function (cardio-thoracic ratio on chest X-ray, left atrial diameter, left ventricular end-diastolic dimension, and left ventricular-ejection fraction by echocardiography), exercise tolerance (6-min walking distance), symptoms, and the number of antiarrhythmic drugs just before and 6 months after PMI. Baseline characteristics were similar between the two groups, except for the number of antiarrhythmic drugs. Six months after PMI, cardiac function, exercise tolerance, and symptoms did not differ significantly between the two groups. Compared to the drug group (p < 0.01), the number of antiarrhythmic drugs was significantly smaller in the AVNA group 6 months after PMI. Patients who underwent AVNA concurrently with PMI with RV lead placement at the mid-septum site for bradycardia-tachycardia syndrome were able to reduce the intake of drugs and improve their tachycardia-related symptoms while maintaining cardiac function and exercise tolerance. More... »

PAGES

174-178

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00380-011-0126-4

DOI

http://dx.doi.org/10.1007/s00380-011-0126-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1018667031

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21505856


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Arrhythmia Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atrioventricular Node", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bradycardia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiac Pacing, Artificial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Catheter Ablation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Exercise Tolerance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Japan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pacemaker, Artificial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recovery of Function", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tachycardia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ventricular Function, Left", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410781.b", 
          "name": [
            "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nagamoto", 
        "givenName": "Yasutsugu", 
        "id": "sg:person.01034262670.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034262670.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410781.b", 
          "name": [
            "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Inage", 
        "givenName": "Tomohito", 
        "id": "sg:person.0761633503.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761633503.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410781.b", 
          "name": [
            "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoshida", 
        "givenName": "Teruhisa", 
        "id": "sg:person.0641327274.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641327274.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410781.b", 
          "name": [
            "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takeuchi", 
        "givenName": "Tomohiro", 
        "id": "sg:person.01027746703.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027746703.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410781.b", 
          "name": [
            "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gondo", 
        "givenName": "Takeki", 
        "id": "sg:person.01073652723.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073652723.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410781.b", 
          "name": [
            "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fukuda", 
        "givenName": "Yujiro", 
        "id": "sg:person.0643175723.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643175723.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410781.b", 
          "name": [
            "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takii", 
        "givenName": "Eiichi", 
        "id": "sg:person.01141766123.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141766123.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biostatistics, Graduate School of Medicine, Kurume University, Kurume, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410781.b", 
          "name": [
            "Department of Biostatistics, Graduate School of Medicine, Kurume University, Kurume, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murotani", 
        "givenName": "Kenta", 
        "id": "sg:person.01002652037.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002652037.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410781.b", 
          "name": [
            "Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Imaizumi", 
        "givenName": "Tsutomu", 
        "id": "sg:person.0754270552.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754270552.85"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00380-008-1121-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019899336", 
          "https://doi.org/10.1007/s00380-008-1121-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-008-1084-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052989302", 
          "https://doi.org/10.1007/s00380-008-1084-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1009795330454", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000754846", 
          "https://doi.org/10.1023/a:1009795330454"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-04-20", 
    "datePublishedReg": "2011-04-20", 
    "description": "Patients often require antiarrhythmic drugs to control tachycardia after permanent pacemaker implantation (PMI) for bradycardia-tachycardia syndrome. We compared atrioventricular nodal ablation (AVNA) to antiarrhythmic drugs after PMI for bradycardia-tachycardia syndrome. Twenty-eight symptomatic patients with bradycardia-tachycardia syndrome, all of which had a long pause after termination of paroxysmal atrial fibrillation, underwent PMI with RV lead placement at the mid-septum site. Among these patients, 14 underwent PMI and AVNA (AVNA group). The remaining 14 patients underwent PMI only, and continued to take anti-arrhythmic drugs (drug group). We compared cardiac function (cardio-thoracic ratio on chest X-ray, left atrial diameter, left ventricular end-diastolic dimension, and left ventricular-ejection fraction by echocardiography), exercise tolerance (6-min walking distance), symptoms, and the number of antiarrhythmic drugs just before and 6\u00a0months after PMI. Baseline characteristics were similar between the two groups, except for the number of antiarrhythmic drugs. Six months after PMI, cardiac function, exercise tolerance, and symptoms did not differ significantly between the two groups. Compared to the drug group (p\u00a0<\u00a00.01), the number of antiarrhythmic drugs was significantly smaller in the AVNA group 6\u00a0months after PMI. Patients who underwent AVNA concurrently with PMI with RV lead placement at the mid-septum site for bradycardia-tachycardia syndrome were able to reduce the intake of drugs and improve their tachycardia-related symptoms while maintaining cardiac function and exercise tolerance.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00380-011-0126-4", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.6077069", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1095887", 
        "issn": [
          "0910-8327", 
          "1615-2573"
        ], 
        "name": "Heart and Vessels", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "27"
      }
    ], 
    "keywords": [
      "bradycardia-tachycardia syndrome", 
      "atrioventricular nodal ablation", 
      "permanent pacemaker implantation", 
      "RV lead placement", 
      "antiarrhythmic drugs", 
      "cardiac function", 
      "pacemaker implantation", 
      "nodal ablation", 
      "lead placement", 
      "tachycardia-related symptoms", 
      "paroxysmal atrial fibrillation", 
      "anti-arrhythmic drugs", 
      "intake of drugs", 
      "baseline characteristics", 
      "symptomatic patients", 
      "atrial fibrillation", 
      "drug groups", 
      "patients", 
      "syndrome", 
      "symptoms", 
      "drugs", 
      "group 6", 
      "months", 
      "implantation", 
      "ablation", 
      "group", 
      "tachycardia", 
      "fibrillation", 
      "placement", 
      "intake", 
      "long pauses", 
      "tolerance", 
      "function", 
      "number", 
      "sites", 
      "termination", 
      "pauses", 
      "characteristics", 
      "underwent PMI", 
      "mid-septum site", 
      "AVNA group 6"
    ], 
    "name": "Atrioventricular nodal ablation versus antiarrhythmic drugs after permanent pacemaker implantation for bradycardia-tachycardia syndrome", 
    "pagination": "174-178", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1018667031"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00380-011-0126-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21505856"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00380-011-0126-4", 
      "https://app.dimensions.ai/details/publication/pub.1018667031"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:17", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_555.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00380-011-0126-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00380-011-0126-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00380-011-0126-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00380-011-0126-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00380-011-0126-4'


 

This table displays all metadata directly associated to this object as RDF triples.

255 TRIPLES      22 PREDICATES      90 URIs      79 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00380-011-0126-4 schema:about N2e34f5e2f0ce4220bf2e86a46677fde2
2 N37f34169664f45bdaa0a19ce187e8a84
3 N3dcea58705f4484ea5f98398fdc89a5a
4 N59375905f781443f9a60e21d8070c585
5 N5a655154fd5e4ab8b07ab56e7281588a
6 N61c49578ee3043f5909a3e4f175f3e39
7 N64fa72653e424419941c118125f4572c
8 N8aa5dfe0e5c2467992afc645431c4428
9 N93a009abfc2f4fdb8eeebd045d74515c
10 N94aa5f86a517429fbc444fd0f231b179
11 Na11f57b361404893807e386aeb9bcb35
12 Nac3cea285cf742a693276997635e416a
13 Nb5e281d4b78d4790b3e79dc9c692a402
14 Nb8981c7453a14c25915b4e07f12d3e4a
15 Nca609d5f629d4da2b3b3db99077b1e3d
16 Nccc74ec672a84edca7aba20a5af11110
17 Nd1f1ef16387848a0b629ff821f1c5111
18 Ndce1d6932b9f43c08c66b561937ca653
19 Ne11060c820be4e7b9988f3dd3ff07e05
20 Nfa9e5bf63a924f158c84a97713ff5c43
21 anzsrc-for:11
22 anzsrc-for:1102
23 schema:author Nf1b4a133051f4c22be48e95504a8ad56
24 schema:citation sg:pub.10.1007/s00380-008-1084-3
25 sg:pub.10.1007/s00380-008-1121-2
26 sg:pub.10.1023/a:1009795330454
27 schema:datePublished 2011-04-20
28 schema:datePublishedReg 2011-04-20
29 schema:description Patients often require antiarrhythmic drugs to control tachycardia after permanent pacemaker implantation (PMI) for bradycardia-tachycardia syndrome. We compared atrioventricular nodal ablation (AVNA) to antiarrhythmic drugs after PMI for bradycardia-tachycardia syndrome. Twenty-eight symptomatic patients with bradycardia-tachycardia syndrome, all of which had a long pause after termination of paroxysmal atrial fibrillation, underwent PMI with RV lead placement at the mid-septum site. Among these patients, 14 underwent PMI and AVNA (AVNA group). The remaining 14 patients underwent PMI only, and continued to take anti-arrhythmic drugs (drug group). We compared cardiac function (cardio-thoracic ratio on chest X-ray, left atrial diameter, left ventricular end-diastolic dimension, and left ventricular-ejection fraction by echocardiography), exercise tolerance (6-min walking distance), symptoms, and the number of antiarrhythmic drugs just before and 6 months after PMI. Baseline characteristics were similar between the two groups, except for the number of antiarrhythmic drugs. Six months after PMI, cardiac function, exercise tolerance, and symptoms did not differ significantly between the two groups. Compared to the drug group (p < 0.01), the number of antiarrhythmic drugs was significantly smaller in the AVNA group 6 months after PMI. Patients who underwent AVNA concurrently with PMI with RV lead placement at the mid-septum site for bradycardia-tachycardia syndrome were able to reduce the intake of drugs and improve their tachycardia-related symptoms while maintaining cardiac function and exercise tolerance.
30 schema:genre article
31 schema:inLanguage en
32 schema:isAccessibleForFree false
33 schema:isPartOf N7164d1e5550648669c786e06cea4a336
34 Ne607aa5f57a44df8992cffe990c27ff1
35 sg:journal.1095887
36 schema:keywords AVNA group 6
37 RV lead placement
38 ablation
39 anti-arrhythmic drugs
40 antiarrhythmic drugs
41 atrial fibrillation
42 atrioventricular nodal ablation
43 baseline characteristics
44 bradycardia-tachycardia syndrome
45 cardiac function
46 characteristics
47 drug groups
48 drugs
49 fibrillation
50 function
51 group
52 group 6
53 implantation
54 intake
55 intake of drugs
56 lead placement
57 long pauses
58 mid-septum site
59 months
60 nodal ablation
61 number
62 pacemaker implantation
63 paroxysmal atrial fibrillation
64 patients
65 pauses
66 permanent pacemaker implantation
67 placement
68 sites
69 symptomatic patients
70 symptoms
71 syndrome
72 tachycardia
73 tachycardia-related symptoms
74 termination
75 tolerance
76 underwent PMI
77 schema:name Atrioventricular nodal ablation versus antiarrhythmic drugs after permanent pacemaker implantation for bradycardia-tachycardia syndrome
78 schema:pagination 174-178
79 schema:productId N1ae0f0c92a3d4fcfa276a19485e4e228
80 N78484414b3344d40b62f5097bd8dad3c
81 Nd6b37baefeb140b7a7f3092a2af7e670
82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018667031
83 https://doi.org/10.1007/s00380-011-0126-4
84 schema:sdDatePublished 2021-11-01T18:17
85 schema:sdLicense https://scigraph.springernature.com/explorer/license/
86 schema:sdPublisher N138a53a364914330bcf84deeb4c734e9
87 schema:url https://doi.org/10.1007/s00380-011-0126-4
88 sgo:license sg:explorer/license/
89 sgo:sdDataset articles
90 rdf:type schema:ScholarlyArticle
91 N138a53a364914330bcf84deeb4c734e9 schema:name Springer Nature - SN SciGraph project
92 rdf:type schema:Organization
93 N1ae0f0c92a3d4fcfa276a19485e4e228 schema:name dimensions_id
94 schema:value pub.1018667031
95 rdf:type schema:PropertyValue
96 N2e34f5e2f0ce4220bf2e86a46677fde2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Combined Modality Therapy
98 rdf:type schema:DefinedTerm
99 N37f34169664f45bdaa0a19ce187e8a84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Humans
101 rdf:type schema:DefinedTerm
102 N3dcea58705f4484ea5f98398fdc89a5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Japan
104 rdf:type schema:DefinedTerm
105 N4904d7205c3d453b934219c65e263de5 rdf:first sg:person.0761633503.14
106 rdf:rest N836fb951cdd84c8bb73fbb45e053548e
107 N59375905f781443f9a60e21d8070c585 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Atrioventricular Node
109 rdf:type schema:DefinedTerm
110 N5a655154fd5e4ab8b07ab56e7281588a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Aged
112 rdf:type schema:DefinedTerm
113 N61c49578ee3043f5909a3e4f175f3e39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Female
115 rdf:type schema:DefinedTerm
116 N64fa72653e424419941c118125f4572c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Cardiac Pacing, Artificial
118 rdf:type schema:DefinedTerm
119 N7164d1e5550648669c786e06cea4a336 schema:volumeNumber 27
120 rdf:type schema:PublicationVolume
121 N78484414b3344d40b62f5097bd8dad3c schema:name pubmed_id
122 schema:value 21505856
123 rdf:type schema:PropertyValue
124 N7ad7473f1dba413ca95b0428fa7daae0 rdf:first sg:person.0754270552.85
125 rdf:rest rdf:nil
126 N836fb951cdd84c8bb73fbb45e053548e rdf:first sg:person.0641327274.56
127 rdf:rest Nf3db4d14f360456c8005a97a64ba4dc3
128 N8aa5dfe0e5c2467992afc645431c4428 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Aged, 80 and over
130 rdf:type schema:DefinedTerm
131 N93a009abfc2f4fdb8eeebd045d74515c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Male
133 rdf:type schema:DefinedTerm
134 N94aa5f86a517429fbc444fd0f231b179 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Tachycardia
136 rdf:type schema:DefinedTerm
137 N97c556d8b5d24f109b8964f7521750cf rdf:first sg:person.01073652723.93
138 rdf:rest Nc68230ae153146769532cb49a6161079
139 N9898dce6fd5f467cb2971d5c8abf4759 rdf:first sg:person.01002652037.58
140 rdf:rest N7ad7473f1dba413ca95b0428fa7daae0
141 Na11f57b361404893807e386aeb9bcb35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Exercise Tolerance
143 rdf:type schema:DefinedTerm
144 Nac3cea285cf742a693276997635e416a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Time Factors
146 rdf:type schema:DefinedTerm
147 Nb5e281d4b78d4790b3e79dc9c692a402 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Pacemaker, Artificial
149 rdf:type schema:DefinedTerm
150 Nb8981c7453a14c25915b4e07f12d3e4a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Anti-Arrhythmia Agents
152 rdf:type schema:DefinedTerm
153 Nc68230ae153146769532cb49a6161079 rdf:first sg:person.0643175723.52
154 rdf:rest Nd7a4942e30cf40d7b74766204c76f67b
155 Nca609d5f629d4da2b3b3db99077b1e3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Treatment Outcome
157 rdf:type schema:DefinedTerm
158 Nccc74ec672a84edca7aba20a5af11110 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Syndrome
160 rdf:type schema:DefinedTerm
161 Nd1f1ef16387848a0b629ff821f1c5111 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Bradycardia
163 rdf:type schema:DefinedTerm
164 Nd6b37baefeb140b7a7f3092a2af7e670 schema:name doi
165 schema:value 10.1007/s00380-011-0126-4
166 rdf:type schema:PropertyValue
167 Nd7a4942e30cf40d7b74766204c76f67b rdf:first sg:person.01141766123.96
168 rdf:rest N9898dce6fd5f467cb2971d5c8abf4759
169 Ndce1d6932b9f43c08c66b561937ca653 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Recovery of Function
171 rdf:type schema:DefinedTerm
172 Ne11060c820be4e7b9988f3dd3ff07e05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Catheter Ablation
174 rdf:type schema:DefinedTerm
175 Ne607aa5f57a44df8992cffe990c27ff1 schema:issueNumber 2
176 rdf:type schema:PublicationIssue
177 Nf1b4a133051f4c22be48e95504a8ad56 rdf:first sg:person.01034262670.36
178 rdf:rest N4904d7205c3d453b934219c65e263de5
179 Nf3db4d14f360456c8005a97a64ba4dc3 rdf:first sg:person.01027746703.92
180 rdf:rest N97c556d8b5d24f109b8964f7521750cf
181 Nfa9e5bf63a924f158c84a97713ff5c43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Ventricular Function, Left
183 rdf:type schema:DefinedTerm
184 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
185 schema:name Medical and Health Sciences
186 rdf:type schema:DefinedTerm
187 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
188 schema:name Cardiorespiratory Medicine and Haematology
189 rdf:type schema:DefinedTerm
190 sg:grant.6077069 http://pending.schema.org/fundedItem sg:pub.10.1007/s00380-011-0126-4
191 rdf:type schema:MonetaryGrant
192 sg:journal.1095887 schema:issn 0910-8327
193 1615-2573
194 schema:name Heart and Vessels
195 schema:publisher Springer Nature
196 rdf:type schema:Periodical
197 sg:person.01002652037.58 schema:affiliation grid-institutes:grid.410781.b
198 schema:familyName Murotani
199 schema:givenName Kenta
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002652037.58
201 rdf:type schema:Person
202 sg:person.01027746703.92 schema:affiliation grid-institutes:grid.410781.b
203 schema:familyName Takeuchi
204 schema:givenName Tomohiro
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027746703.92
206 rdf:type schema:Person
207 sg:person.01034262670.36 schema:affiliation grid-institutes:grid.410781.b
208 schema:familyName Nagamoto
209 schema:givenName Yasutsugu
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034262670.36
211 rdf:type schema:Person
212 sg:person.01073652723.93 schema:affiliation grid-institutes:grid.410781.b
213 schema:familyName Gondo
214 schema:givenName Takeki
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073652723.93
216 rdf:type schema:Person
217 sg:person.01141766123.96 schema:affiliation grid-institutes:grid.410781.b
218 schema:familyName Takii
219 schema:givenName Eiichi
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141766123.96
221 rdf:type schema:Person
222 sg:person.0641327274.56 schema:affiliation grid-institutes:grid.410781.b
223 schema:familyName Yoshida
224 schema:givenName Teruhisa
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641327274.56
226 rdf:type schema:Person
227 sg:person.0643175723.52 schema:affiliation grid-institutes:grid.410781.b
228 schema:familyName Fukuda
229 schema:givenName Yujiro
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643175723.52
231 rdf:type schema:Person
232 sg:person.0754270552.85 schema:affiliation grid-institutes:grid.410781.b
233 schema:familyName Imaizumi
234 schema:givenName Tsutomu
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754270552.85
236 rdf:type schema:Person
237 sg:person.0761633503.14 schema:affiliation grid-institutes:grid.410781.b
238 schema:familyName Inage
239 schema:givenName Tomohito
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761633503.14
241 rdf:type schema:Person
242 sg:pub.10.1007/s00380-008-1084-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052989302
243 https://doi.org/10.1007/s00380-008-1084-3
244 rdf:type schema:CreativeWork
245 sg:pub.10.1007/s00380-008-1121-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019899336
246 https://doi.org/10.1007/s00380-008-1121-2
247 rdf:type schema:CreativeWork
248 sg:pub.10.1023/a:1009795330454 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000754846
249 https://doi.org/10.1023/a:1009795330454
250 rdf:type schema:CreativeWork
251 grid-institutes:grid.410781.b schema:alternateName Department of Biostatistics, Graduate School of Medicine, Kurume University, Kurume, Japan
252 Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan
253 schema:name Department of Biostatistics, Graduate School of Medicine, Kurume University, Kurume, Japan
254 Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahi-machi, 830-0011, Kurume, Japan
255 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...